Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-03-24 @ 3:02 AM
Study NCT ID:
NCT05757466
Status:
RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
Sponsor:
St. Petersburg State Pavlov Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-17
First Submit QC Date:
None
Study First Post Date:
2023-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-16
Last Update Post Date:
2023-12-19
Last Update Post Date Type:
ACTUAL